Cinven merges Mercury, Amdipharm with £388.6m add-on
Private equity firm Cinven wants to raise £280m of senior loans and a £108.6m mezzanine facility to merge its latest acquisition Amdipharm with its September purchase Mercury Pharma. The new group will be called CCM Pharma.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
